Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00029 | MC-Val-Cit-PAB-MMAE | 646502-53-6 |
| MC-Val-Cit-PAB-MMAE is a potent tubulin inhibitor (MMAE), Val-Cit-PAB-MMAE is an antibody drug conjugate. | Inquiry | |
| BADC-00040 | Dolastatin 10 | 110417-88-4 |
| Dolastatin 10 is a potent antimitotic peptide from a marine animal, strongly inhibiting microtubule assembly. | Inquiry | |
| BADC-00026 | Mc-MMAD | 1401963-15-2 |
| Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is a toxin payload in antibody drug conjugate; Mc-MMAD is a protective group (maleimidocaproyl) -conjugated MMAD. | Inquiry | |
| BADC-00008 | Val-Cit-PAB-MMAE | 644981-35-1 |
| Val-Cit-PAB-MMAE, a tubulin polymerase inhibitor, is a drug-linker conjugate for ADC. It contains an ADC linker (peptide Val-Cit-PAB) and a potent tubulin inhibitor MMAE. | Inquiry | |
| BADC-00016 | Vat-Cit-PAB-MMAD | 1415329-13-3 |
| Vat-Cit-PAB-MMAD is a protective group conjugated MMAD, MMAD is a toxin payload in antibody drug conjugate. | Inquiry | |
| BADC-00635 | MMAE-[d8] | 2070009-72-0 |
| MMAE-[d8] is a labelled analogue of MMAE, which is a potent mitotic inhibitor and a tubulin inhibitor. | Inquiry | |
| BADC-00751 | DBCO-PEG4-MMAF | 2360411-65-8 |
| DBCO-PEG4-MMAF is a drug-linker conjugate for ADC by using Monomethylauristatin F (MMAF,a potent tubulin polymerization inhibitor), linked via DBCO-PEG4. | Inquiry | |
| BADC-00843 | D8-MMAD | |
| D8-MMAD is a deuterated form of MMAD, which is a microtubule disrupting agent. | Inquiry | |
| BADC-00844 | D8-MMAF hydrochloride | |
| D8-MMAF hydrochloride is a deuterated form of MMAF hydrochloride, which is a microtubule disrupting agent. | Inquiry | |
| BADC-00855 | SuO-Glu-Val-Cit-PAB-MMAE | 1895916-24-1 |
| SuO-Glu-Val-Cit-PAB-MMAE consists a cleavable ADC linker (SuO-Glu-Val-Cit-PAB) and a potent tubulin inhibitor (MMAE). SuO-Glu-Val-Cit-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00856 | MMAE-SMCC | 2021179-11-1 |
| MMAE-SMCC is a drug-linker conjugate for ADC. MMAE-SMCC is composed of a potent mitotic and a tubulin inhibitor MMAE and a linker SMCC to make antibody drug conjugate. | Inquiry | |
| BADC-00863 | DBCO-PEG4-Val-Cit-PAB-MMAF | 2244602-23-9 |
| DBCO-PEG4-Val-Cit-PAB-MMAF consists a cleavable 4 unit PEG ADC linker (DBCO-PEG4-Val-Cit-PAB) and a potent tubulin polymerization inhibitor (MMAF). DBCO-PEG4-Val-Cit-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00864 | SC-VC-PAB-MMAE | 2259318-46-0 |
| SC-VC-PAB-MMAE is a drug-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the cleavable linker SC-VC-PAB. | Inquiry | |
| BADC-00866 | Mal-Phe-C4-VC-PAB-MMAE | 2259318-51-7 |
| Mal-Phe-C4-VC-PAB-MMAE is made by MMAE conjugated to Mal-Phe-C4-VC-PAB linker. Monomethyl auristatin E (MMAE), a potent tubulin inhibitor, is a toxin payload in antibody drug conjugate. | Inquiry | |
| BADC-00868 | DBCO-(PEG2-VC-PAB-MMAE)2 | 2259318-55-1 |
| DBCO-(PEG2-VC-PAB-MMAE)2 is made by MMAE conjugated to the cleavable DBCO-(PEG2-VC-PAB)2 linker. Monomethyl auristatin E (MMAE), a potent tubulin inhibitor, is a toxin payload in antibody drug conjugate. | Inquiry | |
| BADC-01348 | Val-Cit-PAB-MMAE TFA salt | 1608127-32-7 |
| Val-Cit-PAB-MMAE TFA salt, a tubulin polymerase inhibitor, is a drug-linker conjugate for ADC. It contains an ADC linker (peptide Val-Cit-PAB) and a potent tubulin inhibitor MMAE. | Inquiry | |
| BADC-01361 | Duostatin 5 | 2124210-34-8 |
| Duostatin 5 is a cytotoxin similar to dolastatin, and it has the advantages of simple synthesis and stability. | Inquiry | |
| BADC-01458 | SuO-Val-Cit-PAB-MMAE | |
| SuO-Val-Cit-PAB-MMAE is part of an antibody drug conjugate (drug-linker conjugate for ADC). Consists of the peptide SuO-Val-Cit-PAB linked to the antimitotic agent MMAE, a tubulin inhibitor. | Inquiry | |
| BADC-01459 | MC-betaglucuronide-MMAE-1 | 1703778-92-0 |
| MC-betaglucuronide-MMAE-1 is part of an antibody-drug conjugate consisting of tubulin polymerization inhibitor MMAE and degradable ADC linker MC-betaglucuronide. | Inquiry | |
| BADC-01460 | DBM-MMAF | 1810001-93-4 |
| DBM-MMAF is composed of linker DBM and toxic molecule MMAF, which can be used to prepare antibody-conjugated drugs. | Inquiry |
